technetium-tc-99m-pyrophosphate has been researched along with Polymyositis* in 2 studies
2 other study(ies) available for technetium-tc-99m-pyrophosphate and Polymyositis
Article | Year |
---|---|
99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease.
We aimed to assess the specificity and sensitivity of (99m)technetium pyrophosphate muscle scintigraphy in the diagnostic workup of patients with suspected myopathy. We reviewed the charts of 166 patients; 52% of the subjects had myalgias, 36% had muscle weakness, 45% had an elevated serum creatine kinase (CK), and 49% had an increased C reactive protein (CRP). Scintigraphy was positive in 34 patients (20%). The test was more sensitive in the presence of muscle weakness, elevated CK, or increased CRP. The presence of myalgias did not influence the odds. Sensitivity was 60% in patients with the final diagnosis of polymyositis, dermatomyositis, or inclusion body myositis, and 70% in noninflammatory myopathies. Eight percent had false positive scintigrams. In individuals with biopsy-proven myopathy (51 subjects), the diagnostic sensitivity was 43%, and its specificity was 60%. Low positive and high negative likelihood ratios (5.0 and 0.65, respectively) document an only limited diagnostic efficiency of (99m)Tc-PYP scintigraphy in the evaluation of inflammatory and noninflammatory myopathies and suggest that the test is not helpful in the routine diagnostic workup of muscle complaints, even after a priori selection of patients for CK plus CRP abnormalities. Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Creatine Kinase; Female; Humans; Male; Middle Aged; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Pain; Polymyositis; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Pyrophosphate | 2007 |
Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: clinical implications.
To determine the role of scintigraphy in the detection of skeletal and cardiac involvement in dermato- and polymyositis (DM/PM), we studied 30 patients with a confirmed diagnosis of DM/PM (23 females, 7 males; mean age: 35 years). Technetium-99m pyrophosphate (99mTc-PYP) and gallium-67 scans showed similar sensitivity, specificity and accuracy in the detection of skeletal muscle involvement when compared with serum enzymes (70%, 100% and 80%, respectively). Compared with the clinical parameters, 99mTc-PYP showed 70% and 67Ga 65% accuracy. Abnormal PYP cardiac uptake was observed in 57% of patients, whereas abnormal 67Ga cardiac uptake was seen in only 15%. Electrocardiography was abnormal in 40%, rest gated blood pool study in 23%, and chest X-ray in 13%. In conclusion, both 99mTc-PYP and 67Ga can be useful in the detection of the active phase of muscle disease. However, 99mTc-PYP seems to be more effective than 67Ga in the early diagnosis of cardiac involvement. Topics: Adolescent; Adult; Child; Clinical Enzyme Tests; Dermatomyositis; Electrocardiography; Female; Gallium Radioisotopes; Gated Blood-Pool Imaging; Heart; Humans; Male; Middle Aged; Muscle, Skeletal; Polymyositis; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Pyrophosphate | 1996 |